Schedule 13G ownership disclosure

Akebia Therapeutics Inc

Security class unavailable · CUSIP: 00972D105

Event date: 2018-02-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-040491
Form type
SC 13G
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Feb 13, 2018
Reporting period
Feb 02, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub